Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting the motor system. As healthcare professionals, a comprehensive understanding of PD is essential for effective diagnosis and management.
The exact cause of PD remains unknown. However, it is widely accepted that a combination of genetic and environmental factors plays a significant role. The disease is characterized by the death of dopamine-producing neurons in the substantia nigra, a region in the midbrain, leading to a dopamine deficiency.
PD typically presents with motor symptoms such as bradykinesia, resting tremor, and rigidity. Non-motor symptoms, including autonomic dysfunction, cognitive impairment, and mood disorders, may also be present. The progression of symptoms varies widely among patients.
PD is primarily diagnosed based on clinical criteria, including the presence of bradykinesia and either resting tremor or rigidity. Neuroimaging techniques, such as DaTSCAN, can support the diagnosis, but they are not routinely used due to their high cost and limited availability.
Management of PD focuses on symptomatic treatment. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay of treatment. Non-pharmacological approaches such as physiotherapy and occupational therapy also play a crucial role. In advanced stages, deep brain stimulation may be considered.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its etiology, recognizing its symptoms, and being familiar with the current diagnostic and treatment strategies are key to providing optimal care for patients with PD. As we continue to delve deeper into the intricacies of this disease, we can hope to improve both the quality of life and lifespan of those affected.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation